Histology & Cytology Market Size, Share, Trends, Growth, Consumption, Revenue, Company Analysis and Forecast 2020-2027

Published Date : Nov 2020 | No. of Pages : 200 Pages | Category : Healthcare

The global histology & cytology market size surpassed at US$ 10.30 Bn in 2019 and to reach US$ 27 billion by 2027.

The global histology & cytology market is anticipated to grow at a CAGR of 9% during the forecast period 2020 to 2027. Increasing prevalence of cancer cases worldwide, advancements in pathological research, advent of digital technologies, along with growing support from governments are some of the key factors anticipated to drive the global histology & cytology market during the assessment period. Moreover, the integration of digital technologies such as AI will redefine the histology & cytology market landscape in the upcoming years, and boost efficiency and accuracy of pathological tests.

The global prevalence of cancer has been rising significantly, and the disease is considered the second major cause of death after cardiovascular diseases. Various factors contributing to the rise in the prevalence of cancer include urbanization, tobacco smoking, increasing pollution, changing diet patterns, and increase in the post-reproductive life span. According to the National Cancer Institute, over 1,806,590 new cases of cancer are anticipated to be diagnosed in the U.S. in 2020. Cervical cancer poses a significant threat to the female population in developing regions, and hence prevention as well as control of cervical cancer could be possible by early screening and diagnosis. Therefore, early detection of cervical cancer would improve the survival rate and quality of life of the patients, as it can be treated successfully with various treatment modalities. According to the World Health Organization (WHO), most of the cancer cases are detected in the final stage when they are not curable, especially in developing regions.

Reimbursement for Cancer Screening

  • Government and non-government agencies provide reimbursement for cancer screening tests performed. Medicaid programs in all the states and in the District of Columbia provide reimbursement coverage for breast, cervical, and colorectal cancer screening. However, Medicaid reimbursements differ substantially among the states and are usually below Medicare reimbursement levels. Increase in the reimbursement levels for screening tests could aid in expanding the supply of facilities providing services for Medicaid beneficiaries.
  • Cancer Services Program offers reimbursement for cervical cytology or the Pap smear test once every three years for women aged 40 years and above with an intact cervix and a prior negative test. Furthermore, reimbursement is offered for cervical screening carried out through Pap smear for women aged between 21 years and 29 years at a frequency of three years.

Integration of Digital Technologies to Shape Future of Pathology

Pathology is one of the key elements of the global healthcare ecosystem and in the current day and age, traditional pathological techniques are gradually being replaced with advanced and modern pathological advancements. The onset of digital technologies is likely to shape the future of the global histology & cytology market in terms of boosting efficiency and scalability. Furthermore, the growing adoption of digital technologies is expected to accelerate the speed and accuracy of diagnosis due to which, the concept of digital pathology is gaining considerable traction worldwide.

The growing adoption of digital whole-slide-imaging (WSI) enables pathologists to visualize and capture the complete tissue on the slide in comparison with the view provided by the microscope– a factor that is expected to improve the accuracy of pathological processes and minimize its subjectivity. Digital slides pave the way for computer-assisted quantitative analytics, speedier image search, and efficient retrieval of slides. The global histology & cytology market is expected to take the digital path in the upcoming years, as digital technologies continue to bridge the gap between medical experts and patients. The growing adoption of artificial intelligence (AI) is projected to provide fertile grounds for the growth to the players operating in the current histology & cytology market. Advancements in precision medicine and AI are anticipated to improve care delivery due to which, more number of pathologists around the world are increasing embracing digital technologies. This factor is likely to provide a boost to the global histology & cytology market during the assessment period.

Cytology to Dominate Global Market

In terms of type of examination, the global histology & cytology market has been bifurcated into histology and cytology. The cytology segment has been split into cervical cancer, breast cancer, oral cancer, and others. The cytology segment dominated the market in terms of revenue in 2019. Increase in cases of cancer and rise in demand for diagnosis of the disease boost the growth of the segment.

Instruments & Analysis Software System to be in Demand

Based on product, the global histology & cytology market has been categorized into instruments & analysis software system and consumables & reagents. The instruments & analysis software system dominated the global histology & cytology market in 2019. Rise in product launch for various technologically advanced devices fuels the growth of the segment. However, the consumables & reagents segment is anticipated to expand at the highest CAGR during the forecast period.

Microscopy Methods to Lead Global Market

In terms of test type, the global histology & cytology market has been classified into microscopy methods, flow cytometry, and molecular genetic methods. The microscopy methods segment has been segregated into cytochemistry & histochemistry and immunohistochemistry & immunofluorescence. The molecular genetic methods segment has been split into cytogenic tests, polymerase chain reaction, and others. The microscopy methods segment dominated the global histology & cytology market in 2019. Over the years, the prevalence of cancer has risen rapidly across the globe. According to GLOBOCAN, in 2018, the prevalence of cancer was 43.8 million globally (9.6 million cancer deaths were registered in the same year).

Hospitals and Clinics to be Major End User

Based on end user, the global histology & cytology market has been divided into hospitals & clinics, academic & research institutes, and others. The hospitals & clinics segment dominated the market in terms of revenue in 2019. Hospitals & clinics are especially meant only for detection of diseases. The availability of sophisticated instruments and favorable reimbursement policies for various treatments drive the segment.

North America to Dominate Global Market

The global histology & cytology market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global market in 2019, followed by Europe. North America accounted for a major share of the global histology & cytology market in 2019, owing to early adoption of advanced technologies and well-established healthcare infrastructure, and strategies adopted by key players. The histology & cytology market in Asia Pacific is likely to expand at a high CAGR from 2020 to 2030. Rise in prevalence of cancer across the region is projected to accelerate the growth of the market in the region.

Competition Landscape

Becton, Dickinson and Company, Danaher, and F. Hoffmann-La Roche Ltd. are the three major companies operating in the global histology & cytology market. The global histology & cytology market is fragmented in terms of number of players. Key players in the global market include Abbott, Becton, Dickinson and Company, Danaher, F. Hoffmann-La Roche Ltd., Hologic, Inc., Merck KGaA, PerkinElmer, Inc., Sysmex Corporation, Thermo Fisher Scientific, Inc., and Trivitron Healthcare. New product development through robust R&D activities and merger & acquisitions are the key strategies adopted by these players to operate business in the global histology & cytology market.

Market Segmentation

By Type of Examination

    • Histology  
    • Cytology   
      • Cervical Cancer
      • Breast Cancer
      • Oral Cancer
      • Others

By Product

    • Instruments & Analysis Software System
    • Consumables & Reagents

By Test Type

    • Microscopy Methods       
      • Cytochemistry & Histochemistry
      • Immunohistochemistry & Immunofluoroscence
    • Flow Cytometry
    • Molecular Genetic Methods         
      • Cytogenic Tests
      • Polymerase Chain Reaction
      • Others

By End User

    • Hospitals & Clinics
    • Academic & Research Institutes
    • Others

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific          
    • China
    • India
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Scope of the Report

VRR’s report on the global histology & cytology market studies the past as well as the current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period from 2020 to 2030. The report provides the revenue of the global histology & cytology market for the period 2018–2030, considering 2020 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global histology & cytology market from 2020 to 2030.

The report has been prepared after extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global histology & cytology market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various attributes of the global histology & cytology market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Moreover, the report sheds light on changing competitive dynamics in the global histology & cytology market. These serve as valuable tools for existing market players as well as entities interested in participating in the global histology & cytology market.

The report also delves into the competition landscape of the global histology & cytology market. Key players operating in the global histology & cytology market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global histology & cytology market that have been profiled in this report

Key Questions Answered in Histology & Cytology Report

  1. What is the sales/revenue generated by histology & cytology providers across all regions during the forecast period?
  2. What are the opportunities in the global histology & cytology market?
  3. What are the major drivers, restraints, opportunities, and threats in the global market?
  4. Which region is set to expand at the fastest CAGR during the forecast period?
  5. Which product segment is expected to generate the highest revenue globally in 2030? Which segment is projected to expand at the highest CAGR during the forecast period?
  6. What are the market positions of different companies operating in the global market?

Research Objectives and Research Approach

The comprehensive report on the global histology & cytology market begins with an overview, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that have been appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global histology & cytology market in terms of type of examination, test type, product, end user, and region. Key segments under each criteria have been studied at length, and the market share for each of these at the end of 2030 has been provided. Such valuable insights enable market stakeholders to make informed business decisions for investment in the global histology & cytology market.


Featured Research Reports

  • Featured Research Reports

    Orthopedic Soft Tissue Repair Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2030

    Read more...
  • Featured Research Reports

    Coagulation Analyzer Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2030

    Read more...
  • Featured Research Reports

    Biological Implants Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2030

    Read more...
  • Featured Research Reports

    Automated Dispensing Machines Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2030

    Read more...
  • Featured Research Reports

    Neurodiagnostics Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2030

    Read more...